Blog - Page 3 of 5769 - QualityStocks

MondayOct 26, 2026 10:20 am

QualityStocksNewsBreaks – Adaptogenics Health Corp. (CSE: ADPT) Draws Sector Attention as RFK Jr. Pushes for Safer, Regulated Peptide Access, iHeartRadio Reports

This article has been disseminated on behalf of Adaptogenics Health Corp. and may include paid advertising. Adaptogenics (CSE: ADPT) is in focus as Health and Human Services Secretary Robert F. Kennedy Jr. advocates expanding access to peptide drugs through a regulated marketplace. According to iHeartRadio, citing Reuters, Kennedy said during an Oct. 20 appearance on Fox News that the Trump administration is working to ensure Americans can obtain peptides manufactured in inspected facilities. Acknowledging that the peptides under consideration have not been approved by the Food and Drug Administration ("FDA") as safe or effective, Kennedy argued that consumers would continue…

MondayOct 26, 2026 10:12 am

QualityStocksNewsBreaks – Adaptogenics Health Corp. (CSE: ADPT) in Focus as Trump Administration Advances Peptide Access Policy, AP Reports

This article has been disseminated on behalf of Adaptogenics Health Corp. and may include paid advertising. Adaptogenics (CSE: ADPT) is positioned in a peptide market drawing increased attention as the Trump administration advances plans to ease restrictions on certain peptide compounds. According to The Associated Press via NBC News, the Department of Health and Human Services has submitted an interim access policy to the White House for review that could allow specialty pharmacies to temporarily produce certain peptides, including BPC-157, which is promoted for muscle growth and injury recovery. The proposal follows a July recommendation by external Food and Drug…

MondayOct 26, 2026 9:10 am

QualityStocksNewsBreaks – Oncotelic Therapeutics, Inc. (OTCQB: OTLC) Publishes Peer-Reviewed Study Identifying Four-Gene Signature in Liver Cancer Using AI Platform

Oncotelic Therapeutics (OTCQB: OTLC) announced the publication of a peer-reviewed study in Biomedicines demonstrating how its AI-powered PDAOAI platform helped identify a four-gene prognostic signature in hepatocellular carcinoma ("HCC"), a form of liver cancer. Published Oct. 23, 2026, the study used Partitioned Literature Aggregation ("PLA"), Oncotelic's patented algorithm running on PDAOAI, alongside gene-expression and survival analyses to identify four genes: FKBP1A, EIF4E, RRAGC and PPARGC1A. The signature's association with patient survival was independently validated in a Japanese HCC cohort of 203 patients. The findings support patient stratification for clinical trials of Sapu003, an intravenous formulation of everolimus. Oncotelic Chief Business…

MondayOct 26, 2026 9:00 am

Powermax Minerals Inc.’s (CSE: PMAX) (OTCQB: PWMXF) Option to Acquire Melba North Rare Earth Property Adds ‘Important Land Position’ to Adjacent Hopkins Property

Disseminated on behalf of Powermax Minerals Inc. (CSE: PMAX) (OTCQB: PWMXF) and may include paid advertising. Powermax Minerals, focused on rare earth element projects in North America, has entered into a three-year option agreement to acquire a 100% interest in the Melba North Property The property is underlain by the Clay-Howells Alkalic Rock Complex that is interpreted as a center characterized by LREE-dominant, magnetite-associated and carbonatite-related REE mineralization A 2025 assessment report on the Clay-Howells claim, which included claims listed on the Melba North option schedule, documented 49 samples that returned more than 0.17% total rare earth element oxides (“TREO”)…

FridayOct 23, 2026 3:47 pm

QualityStocksNewsBreaks – SuperQ Quantum Computing Inc. (CSE: QBTQ) (OTCQB: QBTQF) (FSE: 25X) Positions Hybrid Architecture at Intersection of Quantum, AI

Disseminated on behalf of SuperQ Quantum Computing Inc. and may include paid advertisements. SuperQ Quantum (CSE: QBTQ) (OTCQB: QBTQF) (FSE: 25X) is developing an integrated hybrid quantum-computing ecosystem designed to connect quantum processors with traditional computing infrastructure, including CPUs, GPUs, high-performance computing and artificial intelligence. Its flagship Super(TM) platform provides a unified environment for accessing and deploying computational resources, while Super OS(TM) is being developed to orchestrate these resources through a common execution layer. The company is also developing Super Nova(TM), a modular hybrid quantum computer, with its quantum hardware work taking place at the University of Waterloo’s Digital Quantum…

FridayOct 23, 2026 3:26 pm

QualityStocksNewsBreaks – MindWave Innovations Inc. (NYSE American: APUS) Leveraging Four-Part Ecosystem with MindChain at Its Core

MindWave Innovations (NYSE American: APUS) was featured in a recent article that discussed how growing blockchain adoption is increasing demand for specialized infrastructure to support complex digital asset applications and how the company is positioning itself in this evolving market. “Rather than building around a single application or token, MindWave’s newly defined ecosystem is structured around four interconnected components: MindWave as the infrastructure provider, MindChain as the underlying blockchain, MindWaveDAO as the community and governance layer, and $NILA as the utility and governance token,” the publication reads. “At the center is MindChain, an EVM-compatible Layer 2 designed to serve as…

FridayOct 23, 2026 3:11 pm

QualityStocksNewsBreaks – Versus Systems Inc. (NASDAQ: VS) Taps Expertise to Advance Gamification Strategy

Versus Systems (NASDAQ: VS), a provider of gamification and audience engagement technology, recently appointed Brian Goldenberg, CPA, as chief financial officer. Goldenberg brings more than 25 years of financial and operational leadership experience, including previous CFO, COO and chief compliance officer roles at investment management firms. He will also serve as the company’s principal financial officer and principal accounting officer, overseeing key financial reporting and accounting responsibilities. The appointment comes as Versus expands its audience engagement business through its Winfinite customizable web-based gaming platform, Filter Fan Cam live-event technology and a partnership with Drinkfinger that integrates QR-code interactions with digital…

FridayOct 23, 2026 11:05 am

QualityStocksNewsBreaks – QT Imaging Holdings, Inc. (NASDAQ: QTI) Receives Buy Rating, $9 Price Target in D. Boral Capital Initiation of Coverage

QT Imaging (NASDAQ: QTI), a medical technology company developing advanced breast imaging solutions, received a Buy rating and $9 price target from D. Boral Capital in an Oct. 23, 2026, research report titled "Beyond the Mammogram." Analyst Patrick McCann cited growing adoption of the company's Breast Acoustic CT(TM) Scanner, expanding international distribution and potential applications beyond supplemental breast imaging. The scanner produces three-dimensional images without radiation, breast compression or contrast injections, offering additional imaging capabilities particularly for women with dense breast tissue. The report also highlighted potential applications in diagnostic evaluation and oncology treatment monitoring, subject to further clinical validation.…

FridayOct 23, 2026 9:45 am

How Versus Systems Inc. (NASDAQ: VS) Uses Audience Engagement and Gamification to Turn Passive Viewers into Active and Responsive Participants

Versus Systems is a leading provider of gamification and audience engagement technology, with a product ecosystem that includes games, digital platforms, and physical collectibles. The company enhances how audiences interact with content both physically and digitally, and lets brands, teams, and creators add interactive and engaging elements directly into fan experiences. Versus Systems has worked with significant brands such as the NFL, NBA, NHL, MLB, and NCAA teams, engaging more than 10 million customers. Gaining consumer and viewer attention is growing more difficult than ever due to increasingly crowded digital and physical advertising landscapes. Even if a brand is able…

FridayOct 23, 2026 9:00 am

Why Adaptogenics Health Corp. (CSE: ADPT) Is ‘One to Watch’

Disseminated on behalf of Adaptogenics Health Corp. and may include paid advertisements. Adaptogenics is pursuing three complementary opportunities across pharmaceutical-quality peptide supply, proprietary therapeutics and next-generation delivery technologies. Its planned supply network could generate commercial revenue while supporting therapeutic development through external manufacturing and laboratory partners. The company is targeting metabolic health, muscle preservation, mitochondrial function, recovery and healthy ageing through proprietary peptide and small-molecule therapeutics. CEO Dr. J. David Warren brings a scientific record that includes 17 issued patents, while President Antoun Nabhan brings experience spanning more than $2 billion in healthcare transactions and two Nasdaq IPO processes. Adaptogenics…

Site Search

Company Search